![Colin Freund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Freund
Plus aucun poste en cours
Profil
Colin Freund is Chief Executive Officer & Director at Athernal Bio Ltd. and Partner at Delin Ventures Ltd. Former roles include Chief Executive Officer at QUE Oncology, Inc. in 2017, Chief Executive Officer at Modra Pharmaceuticals BV, Chief Business Officer at Transgene SA from 2013 to 2015, and Chief Business Officer & Senior Vice President at Agennix AG.
Education includes an MBA from Stanford University and an undergraduate degree from the University of Cambridge.
Postes actifs de Colin Freund
| Sociétés | Poste | Début |
|---|---|---|
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures invests in companies located in Europe, primarily in the United Kingdom, Germany, Austria, and Switzerland. The firm targets companies operating in the fields of life sciences and manufacturing technologies sectors. It provides financing for pre-seed, seed and early stage capital requirements with an investment size of EUR 0.5 - 2 million. | Private Equity Investor | 01/10/2023 |
Anciens postes connus de Colin Freund
| Sociétés | Poste | Fin |
|---|---|---|
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Directeur Général | 07/06/2017 |
| TRANSGENE | Corporate Officer/Principal | 01/12/2015 |
Modra Pharmaceuticals BV
 Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs | Directeur Général | - |
| AGENNIX AG | Corporate Officer/Principal | - |
Formation de Colin Freund
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Discovers, develops and commercializes new anti-cancer drugs | Health Technology |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Health Technology |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs | Health Technology |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures invests in companies located in Europe, primarily in the United Kingdom, Germany, Austria, and Switzerland. The firm targets companies operating in the fields of life sciences and manufacturing technologies sectors. It provides financing for pre-seed, seed and early stage capital requirements with an investment size of EUR 0.5 - 2 million. | Finance |
